肌肉减少症患者血清AMPK-αmRNA、SIRT1、GDF-8的水平及其临床意义

王琴; 林萍; 任谦; 冯莉; 谢晓枫; 张彬; 高康璐

doi:10.16766/j.cnki.issn.1674-4152.002545

肌肉减少症患者血清AMPK-αmRNA、SIRT1、GDF-8的水平及其临床意义

doi: 10.16766/j.cnki.issn.1674-4152.002545

杭州市第三人民医院老年科，浙江杭州 310009

基金项目:

浙江省医药卫生科技计划项目 2019KY502

杭州市卫生计生科技计划项目 2018A29

杭州市卫生计生科技计划项目 2018Z05

详细信息

通讯作者:
林萍, E-mail: linpingyj@sina.com

中图分类号: R685
计量
- 文章访问数: 200
- HTML全文浏览量: 98
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2021-04-14
- 网络出版日期: 2022-09-23

Serum AMPK-α mRNA, SIRT1 and GDF-8 levels in patients with sarcopenia

Department of the Geriatrics, Hangzhou Third People's Hospital, Hangzhou, Zhejiang 310009, China

摘要

摘要: 目的研究肌少症患者血清腺苷酸活化蛋白激酶-α微小RNA(AMPK-αmRNA)、血清沉默信息调节因子2相关酶1(SIRT1)及血清生长分化因子-8(GDF-8)的水平。方法选择2019年1月—2020年6月杭州市第三人民医院收治的老年患者81例，根据四肢肌肉质量指数、握力及步行速度将患者分为肌肉减少症组(41例)和非肌肉减少症组(40例)，检测血清AMPK-α mRNA、SIRT1及GDF-8等。采用Pearson、Spearman相关性分析相关性；采用ROC曲线分析GDF-8的诊断价值。结果肌少症组与非肌少症组患者各项指标[AMPK-α mRNA: 0.26(0.24，0.29)vs. 0.29(0.27, 0.32);SIRT1(ng/L): 582.68±35.92 vs. 646.50±39.08;GDF-8(μg/L): 20.97±5.10 vs. 14.76±1.59]比较差异均有统计学意义(均P＜0.001)。SIRT1、AMPK-α mRNA与GDF-8呈负相关(P＜0.001, P=0.001)。握力与AMPK-α mRNA及SIRT1呈正相关(P=0.028, P＜0.001)；握力与GDF-8呈负相关(P=0.001)。GDF-8诊断肌少症的临界值是17.25 μg/L，AUC值为0.884(P=0.040)。结论肌少症患者AMPK-α mRNA及SIRT1降低，GDF-8增高，GDF-8可作为肌少症诊断的辅助参考指标。
- 肌肉减少症 /
- 腺苷酸活化蛋白激酶-α微小RNA /
- 血清沉默信息调节因子2相关酶1 /
- 生长分化因子-8
Abstract: Objective To investigate the level of serum AMP-activated protein kinase-α mRNA (AMPK-α mRNA), silent mating type information regulation 2 homolog-1 (SIRT1) and growth differentiation factor-8 (GDF-8) in patients with sarcopenia. Methods A total of 81 elderly patients treated in Hangzhou Third People's Hospital from January 2019 to June 2020 were selected. According to appendicular skeletal mass index (ASMI), grip strength and walking speed, the patients were divided into sarcopenia group (41 cases) and non-sarcopenia group (40 cases). The level of AMPK-α mRNA, SIRT1 and GDF-8 in serum were detected. The correlation was analyzed by Pearson and Spearman correlation. The diagnostic value of GDF-8 was analyzed by ROC curve. Results The data of several indexes of patients in sarcopenia group and non sarcopenia group were as follows [AMPK-α mRNA: 0.26 (0.24, 0.29) vs. 0.29 (0.27, 0.32), SIRT1 (ng/L): 582.68±35.92 vs. 646.50±39.08, GDF-8 (μg/L): 20.97±5.10 vs. 14.76±1.59], the difference was statistically significant (all P < 0.01). SIRT1 and AMPK-α mRNA were negatively correlated with GDF-8 (P < 0.001, P=0.001). The grip strength was positively correlated with AMPK-α mRNA and SIRT1 (P=0.028, P < 0.001), and was negatively correlated with GDF-8 (P=0.001). The critical value of GDF-8 for the diagnosis of sarcopenia was 17.25 μg/L, and AUC was 0.884 (P=0.040). Conclusion AMPK-α mRNA and SIRT1 are decreased and GDF-8 is increased in sarcopenia group. GDF-8 can be used as an auxiliary reference index for the diagnosis of sarcopenia.
- Sarcopenia /
- AMP-activated protein kinase-α microRNA /
- Silent mating type information regulation 2 homolog-1 /
- Growth differentiation factor-8

HTML全文

图 1 GDF-8诊断肌少症的ROC曲线

Figure 1. ROC curve of GDF-8 in diagnosis of sarcopenia

下载: 全尺寸图片幻灯片

表 1 2组老年患者一般情况比较

Table 1. The general conditions of the two groups

组别	例数	性别(男/女，例)	年龄(x±s，岁)	BMI (x±s)	高血压病(例)	冠心病(例)	糖尿病(例)	COPD (例)	CKD (例)	骨质疏松(例)
肌少症组	41	29/12	80.10±3.94	21.12±0.88	22	13	16	18	7	33
非肌少症组	40	27/13	79.38±3.10	21.26±0.69	23	10	18	14	5	34
统计量		0.099^a	0.915^b	-0.797^b	0.121^a	0.448^a	0.297^a	0.671^a	0.336^a	0.288^a
P值		0.753	0.363	0.428	0.728	0.503	0.586	0.413	0.562	0.591
注：^a为χ²值，^b为t值。

下载: 导出CSV

表 2 2组老年患者SIRT1、AMPK-αmRNA、GDF-8、步行速度、ASMI、握力、睾酮、GDF-11和IGF-1比较

Table 2. Comparison of SIRT1, AMPK-αmRNA, GDF-8, walking speed, ASMI, grip strength, testosterone, GDF-11 and IGF-1 between two groups of elderly patients

组别	例数	GDF-11 (x±s, μg/L)	SIRT1 (x±s, ng/L)	AMPK-α mRNA [M(P₂₅, P₇₅)]	IGF-1 (x±s, μg/L)	GDF-8 (x±s, μg/L)
肌少症组	41	171.32±13.49	582.68±35.92	0.26(0.24，0.29)	144.63±10.99	20.97±5.10
非肌少症组	40	261.98±39.52	646.50±39.08	0.29(0.27, 0.32)	247.08±16.12	14.76±1.59
统计量		-13.749^a	-7.656^a	-3.433^b	-33.346^a	7.422^a
P值		＜0.001	＜0.001	0.001	＜0.001	＜0.001

组别	例数	步行速度[M(P₂₅, P₇₅), m/s]	ASMI [M(P₂₅, P₇₅), kg/m²]	握力[M(P₂₅, P₇₅), kg]		睾酮(x±s, nmol/L)
肌少症组	41	0.60(0.58, 0.64)	5.80(5.50, 6.10)	18.20(17.50, 18.65)		7.48±2.34
非肌少症组	40	0.82(0.81, 0.83)	7.20(7.03, 7.30)	26.50(26.30, 27.20)		15.98±2.90
统计量		-7.773^b	-7.765^b	-6.977^b		-14.508^a
P值		＜0.001	＜0.001	＜0.001		＜0.001
注：^a为t值，^b为Z值。

下载: 导出CSV

表 3 SIRT1与GDF-8、GDF-11及IGF-1的相关性分析

Table 3. Correlation analysis of SIRT1 with GDF-8, GDF-11 and IGF-1

项目	r值	P值
GDF-8	-0.544	＜0.001
GDF-11	0.616	＜0.001
IGF-1	0.649	＜0.001

下载: 导出CSV

表 4 AMPK-α mRNA与GDF-8、GDF-11及IGF-1的相关性分析

Table 4. Correlation analysis of AMPK-αmRNA with GDF-8, GDF-11 and IGF-1

项目	r值	P值
GDF-8	-0.359	0.001
GDF-11	0.331	0.001
IGF-1	0.355	0.003

下载: 导出CSV

表 5 握力与ASMI、步行速度、IGF-1、AMPK、SIRT1及GDF-8的相关性分析

Table 5. Correlation analysis of grip strength with ASMI, walking speed, IGF-1, AMPK, SIRT1 and GDF-8

项目	r值	P值
GDF-8	-0.560	＜0.001
IGF-1	0.674	＜0.001
ASMI	0.819	＜0.001
步行速度	0.682	＜0.001
AMPK-α mRNA	0.244	0.028
SIRT1	0.565	＜0.001

下载: 导出CSV

参考文献(21)

[1]	于普林. 老年医学[M]. 2版. 北京: 人民卫生出版社, 2017: 66-68. YU P L. Geriatric Medicine[M]. 2nd Ed. Beijing: People's Medical Publishing House, 2017: 66-68.
[2]	DAS A, HUANG G X, BONKOWSKI M S, et al. Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging[J]. Cell, 2018, 173(1): 74-89. doi: 10.1016/j.cell.2018.02.008
[3]	SAKUMA K, AOI W, YAMAGUCHI A. Molecular mechanism of sarcopenia and cachexia: Recent research advances[J]. Pflugers Arch, 2017, 469(5-6): 573-591. doi: 10.1007/s00424-016-1933-3
[4]	LIU P, HAO Q, HAI S, et al. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: A systematic review and meta-analysis[J]. Maturitas, 2017, 103(9): 16-22.
[5]	张雷, 张小明. 衰弱和脑梗死患者肌少症的关系研究[J]. 河北医学, 2021, 27(4): 659-664. doi: 10.3969/j.issn.1006-6233.2021.04.028 ZHANG L, ZHANG X M. A Study on the Relationship Between Asthenia and Myopathy in Patients with Cerebral Infarction[J]. Hebei Medicine, 2021, 27(4): 659-664. doi: 10.3969/j.issn.1006-6233.2021.04.028
[6]	朱高峰, 罗开涛, 沈志方, 等. 推拿功法易筋经对老年骨骼肌减少症者肌力的影响[J]. 中华全科医学, 2019, 17(8): 1388-1391. doi: 10.16766/j.cnki.issn.1674-4152.000951 ZHU G F, LUO K T, SHEN Z F, et al. Effect of Yijinjing on muscle strength of senile patients with sarcopenia[J]. Chinese Journal of General Practice, 2019, 17(8): 1388-1391. doi: 10.16766/j.cnki.issn.1674-4152.000951
[7]	陈小静, 胡睿, 王海燕, 等. 老年住院患者代谢综合征指标与肌少症的相关性研究[J]. 安徽医学, 2018, 39(12): 1439-1442. doi: 10.3969/j.issn.1000-0399.2018.12.005 CHEN X J, HU R, WANG H Y, et al. Correlation between metabolic syndrome markers and sarcopenia in elderly inpatients[J]. Anhui Medical Journal, 2018, 39(12): 1439-1442. doi: 10.3969/j.issn.1000-0399.2018.12.005
[8]	张翼, 杨波, 王玉波, 等. 老年人肌少症早期筛查与诊断技术研究进展[J]. 北京医学, 2020, 42(12): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX202012013.htm ZHANG Y, YANG B, WANG Y B, et al. Research progress on early screening and diagnosis of sarcopenia in the elderly[J]. Beijing Medcine, 2020, 42(12): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX202012013.htm
[9]	刘丹丹, 冯艳伟, 崔雯霞, 等. 肌少性肥胖研究进展[J]. 中国临床研究, 2019, 32(5): 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201905028.htm LIU D D, FENG Y W, CUI W X, et al. Research progress of sarcopenic obesity[J]. Chinese Journal of Clinical Research, 2019, 32(5): 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201905028.htm
[10]	刘钟桧, 张晓琳, 刘新民. 肌肉减少症与慢性阻塞性肺疾病关系的研究进展[J]. 中华老年医学杂志, 2019, 38(8): 945-948. doi: 10.3760/cma.j.issn.0254-9026.2019.08.029 LIU Z H, ZHANG X L, LIU X M. The recent research progress on relationship between sarcopenia and chronic obstructive pulmonary disease[J]. Chinese Journal of Geriatrics, 2019, 38(8): 945-948. doi: 10.3760/cma.j.issn.0254-9026.2019.08.029
[11]	刘伟, 李圣贤. 男性低雄激素血症睾酮补充治疗的困境及其原因分析[J]. 中华内分泌代谢杂志, 2019, 35(2): 93-98. doi: 10.3760/cma.j.issn.1000-6699.2019.02.001 LIu W, LI S X. The dilemma of testosterone supplementation therapy for male testosterone deficiency and its possible causes[J]. Chinese Journal of Endocrinology and Metabolism, 2019, 35(2): 93-98. doi: 10.3760/cma.j.issn.1000-6699.2019.02.001
[12]	史晓红, 刘章顺, 王利红, 等. 上海地区成年男性血清睾酮、黄体生成素、性激素结合球蛋白变化趋势研究[J]. 诊断学理论与实践, 2018, 17(1): 108-110. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS201801026.htm SHI X H, LIU Z S, WANG L H, et al. Study on the changes of serum testosterone, luteinizing hormone and sex hormone-binding globulin in adult males in Shanghai[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(1): 108-110. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS201801026.htm
[13]	VAN NIEUWPOORT I C, VLOT M C, SCHAAP L A, et al. The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women[J]. Eur J Endocrinol, 2018, 179(2): 73-84. doi: 10.1530/EJE-18-0076
[14]	黄姗姗, 吴江. 炎症性肠病合并肌少症的研究进展[J]. 现代医药卫生, 2020, 36(16): 2486-2489. doi: 10.3969/j.issn.1009-5519.2020.16.003 HUANG S S, WU J. Research progress of inflammatory bowel disease combined with sarcopenia[J]. Journal of Modern Medicine & Health, 2020, 36(16): 2486-2489. doi: 10.3969/j.issn.1009-5519.2020.16.003
[15]	吴高峰, 唐轶, 廖鸿飞, 等. 醋酸兰瑞肽辅助伽玛刀治疗生长激素型垂体腺瘤的临床疗效及对生长激素和胰岛素样生长因子1水平的影响[J]. 癌症进展, 2020, 18(8): 819-821. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ202008016.htm WU G F, TANG Y, LIAO H F, et al. Therapeutic effect of gamma knife treatment and adjuvant lanreotide acetate on growth hormone-secreting pituitary adenoma and the effect on growth hormone and insulin-like growth factor 1 level[J]. Oncology Progress, 2020, 18(8): 819-821. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ202008016.htm
[16]	周景英, 尹玉婷. 类风湿关节炎引起肌少症相关研究进展[J]. 现代医药卫生, 2018, 34(4): 558-560. doi: 10.3969/j.issn.1009-5519.2018.04.025 ZHOU J Y, YIN Y T. Research progress of sarcopenia caused by rheumatoid arthritis[J]. Journal of Modern Medicine & Health, 2018, 34(4): 558-560. doi: 10.3969/j.issn.1009-5519.2018.04.025
[17]	张佳佳, 向光大, 李欢, 等. 生长分化因子11对糖尿病下肢缺血大鼠血管新生的作用研究[J]. 中华内分泌代谢杂志, 2017, 33(11): 965-969. doi: 10.3760/cma.j.issn.1000-6699.2017.11.011 ZHANG J J, XIANG G D, LI H, et al. Effects of growth differentiation factor 11 on angiogenesis in diabetic hindlimb ischemia[J]. Chinese Journal of Endocrinology and Metabolism, 2017, 33(11): 965-969. doi: 10.3760/cma.j.issn.1000-6699.2017.11.011
[18]	潘宁波, 张莹, 杨龙灿, 等. 腺苷酸活化蛋白激酶与缺血再灌注损伤的研究进展[J]. 现代医学, 2020, 48(1): 141-145. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202001030.htm PAN N B, ZHANG Y, YANG L C, et al. Advances in adenylate activated protein kinase and ischemia reperfusion injury[J]. Modern Medical Journal, 2020, 48(1): 141-145. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202001030.htm
[19]	张巍, 房健健, 柴巧英, 等. 外周血miR-34a、SIRT1mRNA表达水平与急性心肌梗死患者PCI术后冠状动脉复流情况的相关性[J]. 国际检验医学杂志, 2021, 42(8): 928-931. doi: 10.3969/j.issn.1673-4130.2021.08.008 ZHANG W, FANG J J, CHAI Q Y, et al. Correlation between mir-34a and SIRT1mRNA expression levels in peripheral blood and coronary artery reflow in patients with acute myocardial infarction after PCI[J]. International Journal of Lab Medicine, 2021, 42(8): 928-931. doi: 10.3969/j.issn.1673-4130.2021.08.008
[20]	孔德琦, 姚桂东, 孙莹璞. 感染过表达Sirtuin1腺病毒对卵巢颗粒细胞的影响[J]. 医药论坛杂志, 2020, 41(7): 33-36. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202007008.htm KONG D Q, YAO G D, SUN Y P. Effects of infection with overexpressed Sirtuin1 adenovirus on ovarian granulosa cells[J]. Journal of Medical Forum, 2020, 41(7): 33-36. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202007008.htm
[21]	刘利利, 赵柯湘, 罗成, 等. 重庆市主城区中老年体检人群肌肉减少症患病率调查及危险因素分析[J]. 中华全科医学, 2019, 17(10): 1762-1767. doi: 10.16766/j.cnki.issn.1674-4152.001050 LIU L L, ZHAO K X, LUO C, et al. Prevalence and risk factors of sarcopenia in urban area of Chongqing[J]. Chinese Journal of General Practice, 2019, 17(10): 1762-1767. doi: 10.16766/j.cnki.issn.1674-4152.001050